|
|
||||||||

* Departments of Medicine and Pediatrics, Harvard Medical School, and Division of Rheumatology, Immunology and Allergy, Brigham and Womens Hospital, Boston, MA 02115; and
Partners Asthma Center, Boston, MA 02115
IL-4 and mast cells (MCs) mediate mucosal defense against helminths and are central to allergic inflammation. Lysophosphatidic acid (LPA), an abundant, potent lipid growth factor, stimulates the growth of cultured human MCs (hMCs) in vitro through a pathway involving LPA receptors 1 and 3 (termed the LPA1 and LPA3 receptors, respectively) and peroxisome proliferator-activated receptor-
. We now report that LPA potently induces the generation of proinflammatory chemokines (MIP-1
, IL-8, and MCP-1) by hMCs by a mechanism that absolutely requires IL-4. The de novo expression of chemokine mRNA and protein generation involves synergistic actions of calcium flux-dependent NFAT transcription factors and ERK. ERK phosphorylation and chemokine production in response to LPA require IL-4-dependent up-regulation of MEK-1 expression by a pathway involving PI3K. Although receptor-selective agonists for both the LPA2 and LPA3 receptors induce calcium fluxes by hMCs, only the LPA2 receptor-selective agonist fatty alcohol phosphate-12 mimics the IL-4-dependent effect of LPA on chemokine generation. The fact that LPA, an endogenous lipid mediator, activates hMCs by an LPA2 receptor-dependent pathway indicates functional distinctions between different LPA receptor family members that are expressed constitutively by cells of a single hemopoietic lineage. Moreover, the regulation of MEK-dependent signaling is a mechanism by which IL-4 could amplify inflammation in mucosal immune responses through receptor systems for endogenous ligands such as LPA.
This article has been cited by other articles:
![]() |
N. Naidoo, M. Ferber, M. Master, Y. Zhu, and A. I. Pack Aging Impairs the Unfolded Protein Response to Sleep Deprivation and Leads to Proapoptotic Signaling J. Neurosci., June 25, 2008; 28(26): 6539 - 6548. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Di Nardo, K. Yamasaki, R. A. Dorschner, Y. Lai, and R. L. Gallo Mast Cell Cathelicidin Antimicrobial Peptide Prevents Invasive Group A Streptococcus Infection of the Skin J. Immunol., June 1, 2008; 180(11): 7565 - 7573. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Oskeritzian, S. E. Alvarez, N. C. Hait, M. M. Price, S. Milstien, and S. Spiegel Distinct roles of sphingosine kinases 1 and 2 in human mast-cell functions Blood, April 15, 2008; 111(8): 4193 - 4200. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Jiang, Y. Kanaoka, C. Feng, K. Nocka, S. Rao, and J. A. Boyce Cutting edge: interleukin 4-dependent mast cell proliferation requires autocrine/intracrine cysteinyl leukotriene-induced signaling. J. Immunol., September 1, 2006; 177(5): 2755 - 2759. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Feng, E. M. Beller, S. Bagga, and J. A. Boyce Human mast cells express multiple EP receptors for prostaglandin E2 that differentially modulate activation responses Blood, April 15, 2006; 107(8): 3243 - 3250. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |